‘TrumpRx’ web site launches in US with promise to lower cost of medication – Worldwide Dispatch

US president has pitched initiative as populist assault on pharmaceutical corporations, however analysts query if costs shall be inexpensive for many individuals.

United States President Donald Trump has launched a brand new web site that he says will decrease the price of prescription medicines, which have lengthy stood out for his or her sky-high costs within the US in contrast with related merchandise all over the world.

Trump introduced the launch of the brand new web site referred to as TrumpRx, which permits shoppers to purchase discounted medicine immediately from pharma corporations, at an occasion on the White Home on Thursday.

“Individuals are going to avoid wasting some huge cash and be wholesome,” Trump mentioned, stating that among the world’s largest drug producers have agreed to deliver down costs below “Most Favoured Nation” agreements in change for avoiding US tariffs.

The web site is launching with financial savings on greater than 40 common medicine, the White Home mentioned.

Customers can search the positioning for the treatment they need, then print out a coupon and current it at a pharmacy to purchase on the discounted value.

The Trump administration has pitched the initiative as a populist assault on highly effective pharmaceutical corporations amid rising discontent over the state of the financial system.

A bunch of 16 drug corporations have agreed to low cost offers, below which they may provide decrease costs for sure medicine to authorities programmes reminiscent of Medicaid and, by way of TrumpRx, to US shoppers.

The TrumpRx website, which guarantees “the world’s lowest costs on prescribed drugs”, showcases greater than 40 drugs, together with weight-loss medicine reminiscent of Ozempic and Wegovy, and calls the trouble “essentially the most impactful prescription value reset within the historical past of our nation”.

“Due to President Trump, the times of Massive Pharma price-gouging are over,” the web site states.

However analysts have questioned whether or not the trouble will substantively deal with US drug costs or shake up the pharmaceutical trade.

“There’s a actual query concerning the worth of this for individuals with insurance coverage,” Juliette Cubanski, deputy director for Medicare coverage at well being coverage organisation KFF, advised the information company Reuters.

“In some circumstances, we could possibly be out-of-pocket prices which might be nonetheless comparatively unaffordable for lots of people,” Cubanski mentioned.

TrumpRx is consultant of the US president’s personalistic type of shaping coverage, looking for to chop particular person offers to advance his personal priorities reasonably than utilizing conventional regulatory and legislative means.

A earlier evaluation by KFF acknowledged that the small print of the Most Favoured Nation agreements with the companies “stay confidential, which signifies that little or no is thought publicly about what precisely has been agreed to”.

Pharmaceutical corporations stay a strong pressure in US politics, with the watchdog group Open Secrets and techniques reporting that pharmaceutical producers spent a record-high $187m on lobbying actions in 2025.